4/A//SEC Filing
Barr Jason Michael 4/A
Accession 0001493152-23-022161
CIK 0000868278other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 8:12 PM ET
Size
6.1 KB
Accession
0001493152-23-022161
Insider Transaction Report
Form 4/AAmended
Barr Jason Michael
Director
Transactions
- Award
Option (right to buy)
2023-06-16+40,000→ 40,000 totalExercise: $7.31Exp: 2030-06-15→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the "Option"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023.
- [F2]This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001645550
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 8:12 PM ET
- Size
- 6.1 KB